Clotrimazole: Difference between revisions
Elcatracho (talk | contribs) |
(Replace manual dosing with dynamic SMW tables) |
||
| Line 12: | Line 12: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===Indications by Disease=== | |||
{{#ask: [[Has DrugName::Clotrimazole]] [[Has Population::Adult]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
|limit=50 | |||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===Indications by Disease=== | |||
{{#ask: [[Has DrugName::Clotrimazole]] [[Has Population::Pediatric]] | |||
|?Treats disease=Disease | |||
|?Has Dose=Dose | |||
|?Has Context=Context | |||
|format=table | |||
|limit=50 | |||
|mainlabel=- | |||
|headers=show | |||
|sort=Treats disease | |||
}} | |||
==Special Populations== | ==Special Populations== | ||
Revision as of 01:54, 20 March 2026
Administration
- Type: Antifungal, azole
- Dosage Forms
- Topical:1% cream
- Vaginal: 100mg supp, 200mg supp; 1% cream, 2% cream
- Oropharyngeal: 10mg troche
- Routes of Administration: topical, oropharyngeal, vaginal
- Common Trade Names
- Topical: Anti-Fungal Liquid, Desenex AF Prescription Strength, FungiCURE Pump Spray, Lotrimin AF Cream, Lotrimin AF For Her, Lotrimin AF Jock Itch, Lotrimin AF Solution, Lotrimin Jock Itch Powder, MPM Anti-Fungal, Prescription Strength Cruex
- Vulvovaginal: Clotrimazole-3, Clotrimazole-7, Femcare, Gyne-Lotrimin, Gyne-Lotrimin 3 Day, Gyne-Lotrimin Combo Pack
- Oropharyngeal: Mycelex Troche
Adult Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Balanoposthitis | 1% applied topically to glans q12hrs until resolution | Antifungal |
| Candida vulvovaginitis | 1% cream applied vaginally for 7 days OR 2% applied vaginally for 3 days | Intravaginal therapy |
| Oropharyngeal candidiasis | 10 mg troches 5 times/day for 14 consecutive days | Adult |
Pediatric Dosing
Indications by Disease
| Disease | Dose | Context |
|---|---|---|
| Oropharyngeal candidiasis | 10mg PO five times daily for 14 days | Pediatric (>3 years) |
Special Populations
- Pregnancy Rating: B (topical, vulvovaginal), C (oropharyngeal)
- Lactation risk: Probably safe (topical, vulvovaginal), Safety unknown (oropharyngeal)
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult: Precaution with troches. Monitor LFTs.
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
may occur but none reported
Common
- Topical
- irritation
- burning/stinging
- pruritus
- erythema
- localized edema
- urticaria
- peeling
- blistering
- Vulvovaginal
- vulvovaginal burning
- vulvovaginal pruritus
- vulvovaginal soreness
- vulvovaginal swelling
- pelvic pain
- pelvic cramps
- abdominal pain
- Oropharyngeal
- vomiting
- nausea
- abdominal cramps
- abnormal LFTs
Pharmacology
- Half-life: Unknown
- Metabolism: liver; CYP450: unknown; Info: minimal systemic absorption
- Excretion: bile/feces primarily, urine
Mechanism of Action
- Exact mechanism of action unknown
- Azole antifungal
- Inhibits 14-alpha demethylase, reducing fungal cell membrane ergosterol synthesis and increasing cellular permeability
Comments
See Also
References
- Epocrates: clotrimazole-oropharyngeal
- Epocrates:clotrimazole-topical
- Epocrates: clotrimazole-vaginal
